Yüklüyor......
Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
PURPOSE. Most guidelines for hormone receptor (HR)–positive early breast cancer recommend addition of adjuvant chemotherapy for most women, leading to overtreatment, which causes considerable morbidity and cost. There has been recent incorporation of gene expression analysis in aiding decision makin...
Kaydedildi:
Asıl Yazarlar: | , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
AlphaMed Press
2010
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227972/ https://ncbi.nlm.nih.gov/pubmed/20421264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0275 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|